Marker Therapeutics (MRKR) Insider Trading & Ownership $1.45 -0.08 (-5.23%) Closing price 04:00 PM EasternExtended Trading$1.45 0.00 (0.00%) As of 05:51 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSustainabilityTrends Marker Therapeutics (NASDAQ:MRKR) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage14.50%Number OfInsiders Buying(Last 12 Months)2Amount OfInsider Buying(Last 12 Months)$1.81 MNumber OfInsiders Selling(Last 12 Months)0 Get MRKR Insider Trade Alerts Want to know when executives and insiders are buying or selling Marker Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address MRKR Insider Buying and Selling by Quarter Marker Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails12/23/2024Enterprise Associates 16 NewMajor ShareholderBuy554,250$3.20$1,773,600.00 12/23/2024Steve ElmsDirectorBuy11,085$3.20$35,472.00 (Data available from 1/1/2013 forward) MRKR Insider Trading Activity - Frequently Asked Questions Who is on Marker Therapeutics's Insider Roster? The list of insiders at Marker Therapeutics includes Enterprise Associates 16 New, Norman David Eansor, and Steve Elms. Learn more on insiders at MRKR. What percentage of Marker Therapeutics stock is owned by insiders? 14.50% of Marker Therapeutics stock is owned by insiders. Learn more on MRKR's insider holdings. Which Marker Therapeutics insiders have been buying company stock? The following insiders have purchased MRKR shares in the last 24 months: Enterprise Associates 16 New ($1,773,600.00), Norman David Eansor ($249,987.50), and Steve Elms ($35,472.00). How much insider buying is happening at Marker Therapeutics? Insiders have purchased a total of 579,620 MRKR shares in the last 24 months for a total of $2,059,059.50 bought. Marker Therapeutics Key ExecutivesDr. Juan F. Vera M.D. (Age 44)Co-Founder, CEO, President, Treasurer, Secretary & Director Compensation: $399.25kMs. Elizabeth DonnellyDirector of AdministrationDr. Maria-Bernadette Madel (Age 34)Director of Corporate Operations & External Communications Mr. Edmund CheungVice President of Human ResourcesDr. Nadia Agopyan Ph.D.Senior Vice President of Regulatory AffairsDr. Monic Stuart M.D.Chief Medical OfficerPatricia AllisonHead of Clinical OperationsDr. Robert Z. Florkiewicz Sr.Senior Director of Molecular Biology & Virology More Insider Trading Tools from MarketBeat Related Companies Aadi Bioscience Insider Selling Clearside Biomedical Insider Selling Mural Oncology Insider Selling Forte Biosciences Insider Selling Aligos Therapeutics Insider Selling Applied Therapeutics Insider Selling vTv Therapeutics Insider Selling Context Therapeutics Insider Selling 23andMe Insider Selling Quince Therapeutics Insider Selling Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles 3 Stocks With Robust Growth Outlooks Insiders Are BuyingMETA Stock: Insider Selling Ramps Up—What It Means for InvestorsThese Are the Dividend Stocks Insiders Bought in JanuaryInsider Selling in Tech Stocks Spikes in Q43 Small-Cap Stocks Insiders and Institutions Are Buying This page (NASDAQ:MRKR) was last updated on 3/3/2025 by MarketBeat.com Staff From Our PartnersDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredElon Musk Wants to Audit Fort Knox—What It Means for Your RetirementYou can take advantage of the coming tariff-fueled gold melt-up right inside your IRA or 401(k) – 100% TAX-FRE...Colonial Metals | SponsoredThe Deep State Surveillance Plot To Sabotage President TrumpThere's a Trump approved IRS-loophole which allows you to steer clear of government overreach and move your re...American Hartford Gold | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredUrgent update to my gold outlookTrump’s Policies Are Fueling a Gold Boom—Here’s Your Chance to Profit Donald Trump’s bold policies are driv...Golden Portfolio | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored3 Undervalued Stocks to Get Today (Revealed)These 3 Stocks Should Do Well Even in a Recession If you’re looking for stocks that offer significant upsid...StockEarnings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Marker Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Marker Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MRKR Stock Alerts